Nrgene's market cap is currently 33.40M. The company's EPS TTM is -40.300000000000004; its P/E ratio is ―; Nrgene is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is ―. See an overview of income statement, balance sheet, and cash flow financials.
